These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3106612)

  • 1. Growth of pathogenic Candida isolates anaerobically and under elevated concentrations of CO2 in air.
    Webster CE; Odds FC
    J Med Vet Mycol; 1987 Feb; 25(1):47-53. PubMed ID: 3106612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of fresh human isolates of some Candida species at 45 degrees C.
    Bezjak V; Chandy R
    J Med Vet Mycol; 1989; 27(3):197-200. PubMed ID: 2674386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of inducible proteinase by pathogenic Candida species.
    Macdonald F
    Sabouraudia; 1984; 22(1):79-82. PubMed ID: 6367100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species.
    Pfaller MA; Boyken L; Messer SA; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2004 Nov; 42(11):4977-9. PubMed ID: 15528683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Mueller-Hinton-agar as a simple medium for the germ tube production of Candida albicans and Candida dubliniensis.
    Rimek D; Fehse B; Göpel P
    Mycoses; 2008 May; 51(3):205-8. PubMed ID: 18399901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida species exhibit differential in vitro hemolytic activities.
    Luo G; Samaranayake LP; Yau JY
    J Clin Microbiol; 2001 Aug; 39(8):2971-4. PubMed ID: 11474025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pathogenicity of eight medically relevant Candida species in an animal model.
    Arendrup M; Horn T; Frimodt-Møller N
    Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of different methods for the identification of Candida species isolated from clinical specimens].
    Cetinkaya Z; Altindiş M; Aktepe OC; Karabiçak N
    Mikrobiyol Bul; 2003 Oct; 37(4):269-76. PubMed ID: 14748264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presumptive identification of Candida albicans by rapid diagnostic tests].
    Vejsová M; Buchta V
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):180-3. PubMed ID: 17080351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony variations in Candida species.
    Odds FC; Merson-Davies LA
    Mycoses; 1989 Jun; 32(6):275-82. PubMed ID: 2674711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid phosphatase production as an aid in rapid characterization of Candida species.
    Sangar VK; Cortes JM; Self LW
    Am J Med Technol; 1975 Sep; 41(9):327-32. PubMed ID: 1101682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media.
    Samaranayake YH; MacFarlane TW; Samaranayake LP; Aitchison TC
    Microbios; 1993; 74(298):23-8. PubMed ID: 8336552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of arabinitol production by pathogenic yeast species.
    Bernard EM; Christiansen KJ; Tsang SF; Kiehn TE; Armstrong D
    J Clin Microbiol; 1981 Aug; 14(2):189-94. PubMed ID: 7024306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three differential media for the presumptive identification of yeasts.
    Yucesoy M; Ozbek OA; Marol S
    Clin Microbiol Infect; 2005 Mar; 11(3):245-7. PubMed ID: 15715727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro.
    Kennedy MJ
    Sabouraudia; 1981 Sep; 19(3):205-8. PubMed ID: 7027476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronidase and chondroitin sulphatase production by different species of Candida.
    Shimizu MT; Jorge AO; Unterkircher CS; Fantinato V; Paula CR
    J Med Vet Mycol; 1995; 33(1):27-31. PubMed ID: 7650575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.